Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by State of Tennessee Department of Treasury

State of Tennessee Department of Treasury trimmed its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 5.2% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 129,705 shares of the medical equipment provider's stock after selling 7,054 shares during the quarter. State of Tennessee Department of Treasury's holdings in Intuitive Surgical were worth $67,701,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in ISRG. Atala Financial Inc acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at about $25,000. Berbice Capital Management LLC purchased a new position in shares of Intuitive Surgical in the fourth quarter valued at approximately $26,000. BankPlus Trust Department purchased a new stake in shares of Intuitive Surgical during the fourth quarter worth approximately $28,000. Hurley Capital LLC acquired a new stake in Intuitive Surgical during the 4th quarter worth $28,000. Finally, Summit Securities Group LLC acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at about $30,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Trading Up 1.3 %

NASDAQ:ISRG traded up $6.46 during midday trading on Friday, hitting $514.59. 2,015,889 shares of the company were exchanged, compared to its average volume of 1,614,267. The company has a fifty day simple moving average of $511.92 and a 200 day simple moving average of $532.42. The company has a market capitalization of $183.29 billion, a PE ratio of 80.28, a price-to-earnings-growth ratio of 5.85 and a beta of 1.55. Intuitive Surgical, Inc. has a fifty-two week low of $367.39 and a fifty-two week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, topping the consensus estimate of $1.71 by $0.10. The company had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same quarter in the previous year, the company posted $1.50 earnings per share. As a group, equities research analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insiders Place Their Bets

In other Intuitive Surgical news, CFO Jamie Samath sold 94 shares of the stock in a transaction that occurred on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the completion of the sale, the chief financial officer now directly owns 2,630 shares of the company's stock, valued at approximately $1,502,019.30. This trade represents a 3.45 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Amal M. Johnson sold 4,635 shares of the company's stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the sale, the director now owns 12,275 shares of the company's stock, valued at $6,955,015. This trade represents a 27.41 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 35,454 shares of company stock valued at $18,564,027. Insiders own 0.70% of the company's stock.

Analysts Set New Price Targets

ISRG has been the subject of a number of analyst reports. Jefferies Financial Group upped their price target on Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. Evercore ISI decreased their target price on shares of Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating on the stock in a report on Wednesday. Bernstein Bank lifted their price target on shares of Intuitive Surgical from $655.00 to $700.00 and gave the company an "overweight" rating in a research report on Monday, January 27th. JPMorgan Chase & Co. increased their target price on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an "overweight" rating in a research note on Friday, January 24th. Finally, Raymond James increased their target price on Intuitive Surgical from $560.00 to $688.00 and gave the stock an "outperform" rating in a research note on Friday, January 24th. Five equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $598.95.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.